Synthesis and Antiplasmodial Activity of EG-Artemisinin Ethers and Artemisinin–Quinoline Hybrids
The aim of this study was to synthesize a series of ethylene glycol (EG) ethers and quinoline hybrids of the antimalarial drug artemisinin and to evaluate their antimalarial activity in vitro against Plasmodium falciparum strains. The ethers were synthesized in a one-step process by coupling ethylene glycol (EG) moieties of various chain lengths to carbon 10 of dihydroartemisinin, while the artemisinin-quinoline hybrids were obtained by condensation of dihydroartemisinin with different amine-functionalized quinoline moieties. For solubility reasons, part of the hybrids were converted to oxalate salts upon reaction of the free bases with oxalic acid. All the synthesized compounds were tested against chloroquine (CQ) susceptible (CQS) D10 and chloroquine resistant (CQR) Dd2 Plasmodium falciparum strains. The IC50 values revealed that all the ethers were active against both strains but less potent than artemether irrespective of the strain. However, they were more active than CQ against the resistant strain. Ether 8 featuring three EO units was the most active of all ethers. It showed activity similar to that of CQ against D10 and much more potency than CQ against Dd2 strain (IC50, 0.023 vs. 0.473 nM). The hybrids and their salts were also all active against both strains. Hybrid 19 which possessed an isopropyl linker and its oxalate salt 19a were the most active against the Dd2 strain. They
were more potent than CQ (IC50, 0.009 and 0.011 vs. 0.255 nM, respectively).
Keywords: Artemisinin (ART), dihydroartemisinin (DHA), artemether (ARM), chloroquine (CQ), malaria, Plasmodium falciparum, ethylene
glycol) (EG), ethylene oxide (EO), hybrid
Copyright for articles published in this journal is retained by the journal.
SAJChem applies the Creative Commons Attribution (CC BY) license to manuscripts we publish. This license was developed to facilitate open access – namely, free immediate access to, and unrestricted reuse of, original works of all types. Under this license, authors agree to make articles legally available for reuse, without permission or fees, for virtually any purpose. Anyone may copy, distribute or reuse these articles, as long as the author and original source are properly cited.